Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur facility
Granules India’s shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing ...
Granules added that manufacturing and distribution of its existing products at the facility will continue unaffected.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results